MG
RMD icon

Marex Group’s ResMed RMD Stock Holding History

Marex Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
+1,287
New +$267K ﹤0.01% 927
2025
Q4 		– Sell
-1,625
Closed -$445K – 1112
2025
Q3 		$445K Buy
1,625
+225
+16% +$61.5K ﹤0.01% 520
2025
Q2 		$361K Sell
1,400
-651
-32% -$155K ﹤0.01% 414
2025
Q1 		$459K Buy
2,051
+1,073
+110% +$250K 0.01% 352
2024
Q4 		$224K Buy
+978
New +$235K ﹤0.01% 516

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marex Group's RMD Position: Q2 2026 in Review

Marex Group opened a new position in ResMed (RMD) in Q2 2026: 1,287 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #927 among its holdings. This is a return to the name: Marex Group previously reported a position in RMD as recently as Q3 2025.

Marex Group first reported a position in RMD in Q4 2024 and has held it in 5 quarters since. The position peaked at $459K in Q1 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Marex Group held 1,287 shares of ResMed worth $251K as of Q2 2026.
  • ResMed was a new Marex Group position in Q2 2026.
  • ResMed made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #927 holding.
  • Marex Group first reported a position in ResMed in Q4 2024 and has held it in 5 quarters since.
  • Marex Group's ResMed position peaked at $459K in Q1 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.